150 related articles for article (PubMed ID: 20529090)
1. RNA interference-mediated silencing of UBCH10 gene inhibits colorectal cancer cell growth in vitro and in vivo.
Chen SM; Jiang CY; Wu JY; Liu B; Chen YJ; Hu CJ; Liu XX
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):525-9. PubMed ID: 20529090
[TBL] [Abstract][Full Text] [Related]
2. Association of clinicopathological features with UbcH10 expression in colorectal cancer.
Chen S; Chen Y; Hu C; Jing H; Cao Y; Liu X
J Cancer Res Clin Oncol; 2010 Mar; 136(3):419-26. PubMed ID: 19779934
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of ubiquitin-conjugating enzyme E2C/UbcH10 expression by RNA interference inhibits glioma cell proliferation and enhances cell apoptosis in vitro.
Jiang L; Bao Y; Luo C; Hu G; Huang C; Ding X; Sun K; Lu Y
J Cancer Res Clin Oncol; 2010 Feb; 136(2):211-7. PubMed ID: 19657671
[TBL] [Abstract][Full Text] [Related]
4. UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer.
Li SZ; Song Y; Zhang HH; Jin BX; Liu Y; Liu WB; Zhang XD; Du RL
Sci Rep; 2014 Nov; 4():6910. PubMed ID: 25376843
[TBL] [Abstract][Full Text] [Related]
5. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
[TBL] [Abstract][Full Text] [Related]
6. NOB1 is essential for the survival of RKO colorectal cancer cells.
He XW; Feng T; Yin QL; Jian YW; Liu T
World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
[TBL] [Abstract][Full Text] [Related]
7. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
8. Silencing of RhoA and RhoC expression by RNA interference suppresses human colorectal carcinoma growth in vivo.
Wang H; Zhao G; Liu X; Sui A; Yang K; Yao R; Wang Z; Shi Q
J Exp Clin Cancer Res; 2010 Sep; 29(1):123. PubMed ID: 20828398
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral vector-mediated downregulation of ornithine decarboxylase inhibits tumor cell growth in vitro and in vivo.
Chi W; Song X; Jiang C; Liu X; Li W; Wang X
Tumour Biol; 2006; 27(5):243-51. PubMed ID: 16888408
[TBL] [Abstract][Full Text] [Related]
10. UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients.
Cacciola NA; Calabrese C; Malapelle U; Pellino G; De Stefano A; Sepe R; Sgariglia R; Quintavalle C; Federico A; Bianco A; Uchimura Bastos A; Milone M; Bellevicine C; Milone F; Carlomagno C; Selvaggi F; Troncone G; Fusco A; Pallante P
Mol Carcinog; 2016 May; 55(5):793-807. PubMed ID: 25917796
[TBL] [Abstract][Full Text] [Related]
11. UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme.
Okamoto Y; Ozaki T; Miyazaki K; Aoyama M; Miyazaki M; Nakagawara A
Cancer Res; 2003 Jul; 63(14):4167-73. PubMed ID: 12874022
[TBL] [Abstract][Full Text] [Related]
12. RNAi-mediated downregulation of DNA binding protein A inhibits tumorigenesis in colorectal cancer.
Liu RT; Wang GR; Liu C; Qiu J; Yan LK; Li XJ; Wang XQ
Int J Mol Med; 2016 Sep; 38(3):703-12. PubMed ID: 27430286
[TBL] [Abstract][Full Text] [Related]
13. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
Hua YQ; Ouyang HQ; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Liu LM
Biomed Pharmacother; 2011 Mar; 65(2):123-31. PubMed ID: 21292437
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated gene silencing of vascular endothelial growth factor inhibits growth of colorectal cancer.
Lv W; Zhang C; Zhou DH; Hao J; Sun JG; Liu T; Hao YX; Yu PW
Cancer Biother Radiopharm; 2007 Dec; 22(6):841-52. PubMed ID: 18158776
[TBL] [Abstract][Full Text] [Related]
15. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of UbcH10 enhances the chemosensitivity of dual drug resistant breast cancer cells to epirubicin and docetaxel.
Wang C; Pan YH; Shan M; Xu M; Bao JL; Zhao LM
Int J Mol Sci; 2015 Mar; 16(3):4698-712. PubMed ID: 25739083
[TBL] [Abstract][Full Text] [Related]
17. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
He XW; Yu X; Liu T; Yu SY; Chen DJ
Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Wang Y; Tang Q; Li M; Jiang S; Wang X
Biochem Biophys Res Commun; 2014 Feb; 444(2):199-204. PubMed ID: 24440701
[TBL] [Abstract][Full Text] [Related]
19. UbcH10 expression in human lymphomas.
Troncone G; Guerriero E; Pallante P; Berlingieri MT; Ferraro A; Del Vecchio L; Gorrese M; Mariotti E; Iaccarino A; Palmieri EA; Zeppa P; Palombini L; Fusco A
Histopathology; 2009 May; 54(6):731-40. PubMed ID: 19438748
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein 70-2 (HSP70-2) is a novel therapeutic target for colorectal cancer and is associated with tumor growth.
Jagadish N; Parashar D; Gupta N; Agarwal S; Suri V; Kumar R; Suri V; Sadasukhi TC; Gupta A; Ansari AS; Lohiya NK; Suri A
BMC Cancer; 2016 Jul; 16():561. PubMed ID: 27473057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
